[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$SAN.PA: Sanofi is transforming into a focused biopharma powerhouse prioritizing long-term innovation over short-term margins. Dupixents sustained double-digit growth and a robust late-stage pipeline show strong future promise. Shares trade at a steep discount to peers despite resilient financials. Could Sanofis coming strategic moves unlock significant value for investors"
X Link @SentinelFlash 2025-10-15T03:49Z XXX followers, XX engagements
"$NOVO remains the cheapest WIDE MOAT among peers according to MS: $NVO price/fair value = XXXX $LLY XXXX $AZN XXXX $SAN.PA XXXX (NARROW) They consider the akero acquisition as accretive (good combination with GLP-1)"
X Link @JomaSilva88 2025-10-12T12:21Z XXX followers, 1321 engagements
"🎯 Picks achat/vente 💚 Zone favorable (sous rserve de bons fondamentaux) EDENRED $EDEN.PA CAPGEMINI $CAP.PA PERNOD RICARD $RI.PA HERMS INTERNATIONAL $RMS.PA DASSAULT SYSTMES $DSY.PA LVMH $MC.PA L'ORAL $OR.PA TELEPERFORMANCE $TEP.PA STELLANTIS $STLAP.PA STMICROELECTRONICS $STMPA.PA SANOFI $SAN.PA AIR LIQUIDE $AI.PA 🟰 Zone Neutre KERING $KER.PA MICHELIN $ML.PA TOTALENERGIES $TTE.PA EUROFINS SCIENTIFIC $ERF.PA VEOLIA ENVIRONNEMENT $VIE.PA CARREFOUR $CA.PA VINCI $DG.PA SCHNEIDER ELECTRIC $SU.PA PUBLICIS GROUPE $PUB.PA RENAULT $RNO.PA ARCELORMITTAL $MT.AS SAINT-GOBAIN $SGO.PA ACCOR $AC.PA 🚨"
X Link @AssetControlPro 2025-10-11T15:03Z 3744 followers, XXX engagements
"Sanofis Orano Med-partnered radioligand therapy AlphaMedix achieved all primary efficacy endpoints Including a measure of overall response rate in the mid-stage ALPHAMEDIX-02 study $SNY $SAN.PA #pharma #radiopharmaceuticals"
X Link @Alpha_Bronze 2025-10-09T14:25Z 7556 followers, XX engagements